Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

PHASE3UnknownINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

November 30, 2000

Conditions
HIV Infections
Interventions
DRUG

Abacavir sulfate

DRUG

Nelfinavir mesylate

DRUG

Lamivudine

DRUG

GW433908

Trial Locations (23)

10011

Gervais Frechette, New York

Howard Grossman, New York

10029

Mount Sinai School of Medicine, New York

10461

Bronx Municipal Hosp Ctr/Jacobi Med Ctr, The Bronx

11201

Addiction Research and Treatment Corp, Brooklyn

14642

Univ of Rochester Med Ctr, Rochester

19107

Thomas Jefferson Univ, Philadelphia

28211

SMO-USA Inc, Charlotte

32801

Florida ID Group, Orlando

33602

Hillsborough County Health Dept, Tampa

33617

Clinical Pharmacology Services, Tampa

60064

Veterans Affairs Med Ctr of North Chicago, Chicago

75038

Walter Gaman, Irving

77054

MacGregor Med Association, Houston

78229

Southwest Texas Methodist Hosp, San Antonio

90803

Ocean View Internal Medicine, Long Beach

94520

East Bay Clinical Trial Ctr, Concord

97401

Advanced Clinical Trials Inc, Eugene

112123198

Brookdale Univ Hosp and Med Ctr, Brooklyn

661607415

Univ of Kansas Med Ctr, Kansas City

775550835

Univ of Texas Med Branch, Galveston

07102

Saint Michael's Med Ctr, Newark

071032757

UMDNJ - New Jersey Med School, Newark

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Glaxo Wellcome

INDUSTRY